Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 20;59(5):e02160-20.
doi: 10.1128/JCM.02160-20. Print 2021 Apr 20.

Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective

Dandan Li  1   2 , Jinming Li  3   2   4
Affiliations
Review

Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective

Dandan Li et al. J Clin Microbiol. .

Abstract

Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally as a severe pandemic. SARS-CoV-2 infection stimulates antigen-specific antibody responses. Multiple serologic tests have been developed for SARS-CoV-2. However, which antigens are most suitable for serological testing remains poorly understood. Specifically, which antigens have the highest sensitivity and specificity for serological testing and which have the least cross-reactivity with other coronaviruses are currently unknown. Previous studies have shown that the S1 domain of the spike (S) protein has very low cross-reactivity between epidemic coronaviruses and common human coronaviruses, whereas the S2 domain of the S protein and the nucleocapsid protein (N protein) show low-level cross-reactivity. Therefore, S1 is considered more specific than the native homotrimer of the S protein, and the receptor-binding domain as an antigen to test patient antibodies is more sensitive than the native N protein. In addition, an increasing number of studies have used multiantigen protein arrays to screen serum from convalescent patients with COVID-19. Antigen combinations demonstrated improved performance compared to each individual antigen. For rapid antigen detection, the sensitivity of the test is higher in the first week of onset of the disease with high viral loads. Highly sensitive and specific immunological diagnostic methods for antibodies or those that directly detect viral antigens in clinical samples would be beneficial for the rapid and accurate diagnosis of SARS-CoV-2 infection.

Keywords: COVID-19; SARS-CoV-2; antigen; cross-reaction; serology testing.

PubMed Disclaimer

Figures

FIG 1
FIG 1
(A) Components of the lateral flow assay strip. (B) Detection principle of a lateral flow assay test. The red square indicates the antigen to be tested, the yellow circle with F indicates the fluorescence, the light green antibody indicates the SARS-CoV-2 capture antibody, the dark green antibody indicates the SARS-CoV-2 detection antibody, and the blue antibody indicates the specific antibodies against fluorescent markers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C, Chai X, He R, Li X, Lv Q, Zhu H, Deng W, Xu Y, Wang Y, Qiao L, Tan Y, Song L, Wang G, Du X, Gao N, Liu J, Xiao J, Su XD, Du Z, Feng Y, Qin C, Qin C, Jin R, Xie XS. 2020. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell 182:73–84.e16. 10.1016/j.cell.2020.05.025. - DOI - PMC - PubMed
    1. He Q, Manopo I, Lu L, Leung BP, Chng HH, Ling AE, Chee LL, Chan SW, Ooi EE, Sin YL, Ang B, Kwang J. 2005. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus. Clin Diagn Lab Immunol 12:321–328. 10.1128/CDLI.12.2.321-328.2005. - DOI - PMC - PubMed
    1. Lou B, Li TD, Zheng SF, Su YY, Li ZY, Liu W, Yu F, Ge SX, Zou QD, Yuan Q, Lin S, Hong CM, Yao XY, Zhang XJ, Wu DH, Zhou GL, Hou WH, Li TT, Zhang YL, Zhang SY, Fan J, Zhang J, Xia NS, Chen Y. 2020. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset. Eur Respir J 56:2000763. 10.1183/13993003.00763-2020. - DOI - PMC - PubMed
    1. Kandeel M, Ibrahim AA, Fayez M, Al-Nazawi M. 2020. From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol 92:660–666. 10.1002/jmv.25754. - DOI - PMC - PubMed
    1. Liu W, Liu L, Kou G, Zheng Y, Ding Y, Ni W, Wang Q, Tan L, Wu W, Tang S, Xiong Z, Zheng S. 2020. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol 58:e00461-20. 10.1128/JCM.00461-20. - DOI - PMC - PubMed

Publication types

Substances